IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP V, LLC

Q2 2026 Holdings

Filed 2026-08-10 | 3 holdings | $498.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rapport Therapeutics, Inc.(RAPP)COM75383L102$261.7M6,280,52552.5%
Septerna, Inc.(SEPN)COM81734D104$208.2M6,215,59141.8%
Maze Therapeutics, Inc.(MAZE)COM578784100$28.4M950,8005.7%